SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies
SNRS 0.0000010000.0%Jun 6 11:01 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TBM700 who wrote (815)4/27/1998 3:08:00 AM
From: Joe   of 4140
 
The other posts in response to yours have hit the regression topic well. In conclusion, from a patient's perspective, I had both of my eyes treated at London Place Eye Centre up in B.C., Canada, nearly 4 years ago (then a late 40's hyperope). I can tell you that the procedure was simple, a quick one sitting in front of a slit lamp taking several seconds per eye. For me it was not totally painless post treatment - there was mild irritation which was controlled with Tylenol and antibotic eye drops. There has been some regression, mostly in the first year, but it has been minor. I still do not need to wear glasses - I have tried my old glasses on and I can't even see through them.

To complete your DD you should be aware of the extensive patent protection of the "Sand" process for using thermal laser energy for shrinking collagen. If you will log onto the IBM patent server, you can take a look at the patents for yourself.

patents.ibm.com

Search for "sand bruce j" (leave out the quotes and do not use a comma between the last and first name) and select 1971 to present. The Sand patents were acquired when Sunrise purchased a company called Laser Biotech. These patents have been refined over the years, as you can see.

In one of the reference posts you will note that Summit Technology (BEAM) had an unsuccessful LTK effort. On the patent issue, it is reassuring to note that back in the year they started their clinicals, they acknowledged the Sand process patents in the notes to their SEC Form 10-K indicating their process might infringe the Sunrise patents.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext